In Stock

Influenza A, H3N2 (A/District of Columbia/27/2023) Reporter Virus Particles

SKU:
RVP-1219L
Maximum Purchase:
10 units
Current Stock:
Virus:
Influenza A (H3N2)
Strain:
A/District of Columbia/27/2023
Unit:
1 mL
Lead Time:
In-stock
$630.00
Infectivity determined in MDCK-SIAT1 cells. Infectivity data represents the average of three independent vials, each tested in quadruplicate.
Reporter Virus Particles (RVP) by Integral Molecular, Inc.

Frequently Bought Together:

Infectivity determined in MDCK-SIAT1 cells. Infectivity data represents the average of three independent vials, each tested in quadruplicate.
Inc. Tax
Ex. Tax

Integral Molecular’s Influenza Reporter Virus Particles (RVPs) are replication-incompetent pseudotyped virus particles that enable safe (BSL-2), easy, and high-throughput viral infectivity and neutralization assays using standard detection instrumentation. The RVPs display hemagglutinin (HA) and neuraminidase (NA) proteins on a heterologous virus core and carry a modified genome that expresses a convenient optical reporter gene. Protocols are provided for neutralization and infectivity assays. 

Target cells are sold separately. 

Product Influenza A, H3N2 Reporter Virus Particles (RVPs)
Catalog Number RVP-1219
Strain District of Columbia/27/2023
Packaging 20% FBS/DMEM
Recommended Input Range 1.25 uL per well (96-well plate)
Target Cell Line MDCK-SIAT-1 cells
Lead time In-stock
Shipping Shipped on dry ice
Storage conditions Store at -80°C (+/- 10°C) upon receipt
Size 1.0 mL/vial